Medicines for Benign Prostatic Hyperplasia (BPH) & Hair Loss[INQ. NO. 1707C14] Founded in 1941, YuYu Pharma, Inc. has developed a number of high-grade prescription medicines such as Tanamin (medicine for dementia and peripheral circulatory disturbance), Maxmarvil (new medicine for osteoporosis treatment), CLID (thromboembolectomy treatment), and Umckamin (medicine for asthma and respiratory infection).
Maxmarvil, the nation’s tenth new medicine, and the first combined new medicine, is used to treat osteoporosis and is widely favored by patients and doctors due to its high efficacy and safety. YuYu also has the distinction of having developed the nation’s second combined new medicine, YUCILD, a cure for stroke.
Dustar Soft Cap. 0.5mg, a generic Avodart (Dutasteride), is for benign prostatic hyperplasia (BPH) and Alopecia (hair loss). Dustar is a 5 alpha-reductase inhibitor effective for BPH, prostate volume reduction and lower urinary tract symptoms (LUTS), and nocturia. In addition, male hair loss occurs when the terthoserone is converted to dihydrotestosterone (DHT), and the Dutasteride prevents hair loss by blocking the 5 alpha-reductase involved in this hormone change. Dutasteride 0.5 mg is prescribed for BPH and male hair loss. Dustar Soft Cap has proven its efficacy and safety with the Avodat it contains. It is expected to lead the prostate medicine market with YY-DUTA, which is being developed to treat BPH. | Blog Magazine of Korean products, brands and Goods